Lu Han

2.4k total citations
71 papers, 1.8k citations indexed

About

Lu Han is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Lu Han has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Lu Han's work include Head and Neck Cancer Studies (12 papers), MicroRNA in disease regulation (9 papers) and Head and Neck Surgical Oncology (7 papers). Lu Han is often cited by papers focused on Head and Neck Cancer Studies (12 papers), MicroRNA in disease regulation (9 papers) and Head and Neck Surgical Oncology (7 papers). Lu Han collaborates with scholars based in China, United States and Singapore. Lu Han's co-authors include Jianji Pan, Jiade J. Lu, Shaojun Lin, Xiuchun Zhang, Qisong Chen, Shaojun Lin, Shujuan Zou, Mengchun Qi, Ivan Weng Keong Tham and Hanxi Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Lu Han

67 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Han China 20 640 546 418 331 313 71 1.8k
Jingfeng Li China 20 1.1k 1.8× 184 0.3× 237 0.6× 145 0.4× 291 0.9× 51 1.7k
Ahmad Waseem United Kingdom 30 1.2k 1.9× 85 0.2× 220 0.5× 215 0.6× 349 1.1× 62 2.5k
Raghu Radhakrishnan India 24 574 0.9× 142 0.3× 157 0.4× 158 0.5× 260 0.8× 129 1.5k
B. Lynn Allen‐Hoffmann United States 24 816 1.3× 61 0.1× 274 0.7× 138 0.4× 378 1.2× 42 2.3k
Rita Mulherkar India 24 990 1.5× 115 0.2× 140 0.3× 142 0.4× 417 1.3× 62 1.7k
Lars Uhlin‐Hansen Norway 27 1.1k 1.8× 113 0.2× 178 0.4× 130 0.4× 688 2.2× 56 2.5k
Randy Todd United States 24 975 1.5× 192 0.4× 174 0.4× 150 0.5× 524 1.7× 49 1.7k
Carlos Caulı́n United States 22 1.1k 1.7× 104 0.2× 604 1.4× 156 0.5× 1.0k 3.3× 41 2.3k
No‐Hee Park United States 23 864 1.4× 95 0.2× 132 0.3× 103 0.3× 438 1.4× 46 1.7k

Countries citing papers authored by Lu Han

Since Specialization
Citations

This map shows the geographic impact of Lu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Han more than expected).

Fields of papers citing papers by Lu Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Han. The network helps show where Lu Han may publish in the future.

Co-authorship network of co-authors of Lu Han

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Han. A scholar is included among the top collaborators of Lu Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Han. Lu Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yong, Chaoji Zhang, Peng Qin, et al.. (2025). Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy. Scientific Reports. 15(1). 28995–28995. 1 indexed citations
2.
Yu, Yingying, Qian Wang, Guangwen Wang, et al.. (2025). Nucleophosmin 1 inhibits the replication of influenza A virus by competitively binding viral RNA with viral proteins. Virologica Sinica. 40(3). 388–400.
3.
Wang, Qian, Wentao Shen, Lu Han, et al.. (2025). N 6-methyladnosine of vRNA facilitates influenza A virus replication by promoting the interaction of vRNA with polymerase proteins. Proceedings of the National Academy of Sciences. 122(11). e2411554122–e2411554122. 4 indexed citations
4.
Yuan, Zhengchao, Xinyi Wang, Peng Li, et al.. (2025). Vascular endothelial growth factor (VEGF) and endogenous calcium-capturing gelatin methacrylate hydrogels promote bone tissue regeneration. Biomaterials. 322. 123352–123352. 10 indexed citations
5.
Yin, Minghao, et al.. (2024). A novel pH-responsive multi-component nanodelivery system with siRNA for plant disease management. Chemical Engineering Journal. 497. 155001–155001. 6 indexed citations
6.
Zhang, Yaping, Qun Zhang, Lu Han, et al.. (2023). SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer. Translational Oncology. 31. 101654–101654. 15 indexed citations
7.
Xu, Shuai, Lu Han, Bo Zhang, et al.. (2022). MicroRNA-200c-targeted contactin 1 facilitates the replication of influenza A virus by accelerating the degradation of MAVS. PLoS Pathogens. 18(2). e1010299–e1010299. 23 indexed citations
8.
Shen, Wentao, Qian Wang, Zhengxiang Wang, et al.. (2022). Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication. Journal of Virology. 96(18). e0123822–e0123822. 6 indexed citations
9.
Liang, Xiaoliang, et al.. (2022). CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma. International Journal of General Medicine. Volume 15. 5661–5672. 5 indexed citations
10.
Han, Lu, Lei Li, & Geng Wu. (2022). Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells. Molecular and Cellular Probes. 64. 101821–101821. 36 indexed citations
11.
Zeng, Yan, Shuai Xu, Xuegang Zhang, et al.. (2021). The PB1 protein of influenza A virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation. PLoS Pathogens. 17(2). e1009300–e1009300. 101 indexed citations
12.
Cao, Ye, et al.. (2020). <p>miR-195 Serves as a Tumor Suppressor in the Progression of Liposarcoma by Targeting OSBP</p>. OncoTargets and Therapy. Volume 13. 6465–6474. 5 indexed citations
13.
Long, Ting, Lu Han, Xiaoyan Yuan, et al.. (2018). Differential Expression Profiles of Circular RNAs During Osteogenic Differentiation of Mouse Adipose-Derived Stromal Cells. Calcified Tissue International. 103(3). 338–352. 30 indexed citations
14.
Luo, Xian, et al.. (2016). Cloning and Expression Analysis of Gibberellin Receptor Gene in Gladiolus hybridus. 36(11). 2158. 1 indexed citations
15.
Han, Lu, et al.. (2013). Therapeutic effect of radiotherapy and chemotherapy in 202 elderly patients with nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 22(6). 461–464. 2 indexed citations
16.
Lin, Shaojun, Jianji Pan, Lu Han, et al.. (2013). Long-term outcome of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiotherapy and chemotherapy. Zhonghua fangshe zhongliuxue zazhi. 22(5). 378–382. 1 indexed citations
17.
Han, Lu, et al.. (2010). Impact of reducing clinical target volume on efficacy of intensity modulated radiation therapy for nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 19(4). 283–287. 1 indexed citations
18.
Lin, Shaojun, Jiade J. Lu, Lu Han, Qisong Chen, & Jianji Pan. (2010). Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases. BMC Cancer. 10(1). 39–39. 136 indexed citations
19.
Han, Lu, Shaojun Lin, Yimin Li, & Jianji Pan. (2009). Therapeutic results of 46 patients with initially diagnosed metastatic nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 18(3). 170–172. 1 indexed citations
20.
Han, Jun, Chenfang Dong, Li Sun, et al.. (2007). Generation of genetic engineering monoclonal antibodies against prion protein. Medical Microbiology and Immunology. 196(4). 241–246. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingfeng Li Breakdown of academic impact, for papers by Ahmad Waseem Breakdown of academic impact, for papers by Raghu Radhakrishnan Breakdown of academic impact, for papers by B. Lynn Allen‐Hoffmann Breakdown of academic impact, for papers by Rita Mulherkar Breakdown of academic impact, for papers by Lars Uhlin‐Hansen Breakdown of academic impact, for papers by Randy Todd Breakdown of academic impact, for papers by Carlos Caulı́n Breakdown of academic impact, for papers by No‐Hee Park
Rankless by CCL
2026